Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Fitzgerald
E Michael

Showing results (851-860 of 2,771) with videos related to

Pageof 278
Sort By:
Therapeutic Advances in Musculoskeletal Disease|November 3, 2018
New and emerging concepts in the use of denosumab for the treatment of osteoporosisE Michael Lewiecki
North Carolina Medical Journal|September 1, 2019
More Than Health Care Services: North Carolina's Focus on Improving Whole-person Health and Patient ExperienceKaren E Michael
Nursing Management|June 7, 2002
DNR orders: proceed with cautionJanet E Michael
Journal of Muscle Research and Cell Motility|March 13, 2003
2,3-Butanedione monoxime (BDM) as a myosin inhibitorE Michael Ostap
Home Healthcare Nurse|August 15, 2003
What home healthcare nurses should know about fraud and abuseJanet E Michael
Expert Opinion on Investigational Drugs|October 10, 2007
Bazedoxifene and bazedoxifene combined with conjugated estrogens for the management of postmenopausal osteoporosisE Michael Lewiecki
Expert Opinion on Biological Therapy|January 26, 2010
Denosumab--an emerging treatment for postmenopausal osteoporosisE Michael Lewiecki
Advances in Experimental Medicine and Biology|February 13, 2009
Tropomyosins as discriminators of myosin functionE Michael Ostap
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|September 2, 2008
A clinician's perspective on the use of zoledronic acid in the treatment of postmenopausal osteoporosisE Michael Lewiecki
Current Osteoporosis Reports|June 18, 2010
Bone densitometry and vertebral fracture assessmentE Michael Lewiecki
Pageof 278

Showing results (851-860 of 2,771) with videos related to

Sort By:
Pageof 278
Therapeutic Advances in Musculoskeletal Disease|November 3, 2018
New and emerging concepts in the use of denosumab for the treatment of osteoporosisE Michael Lewiecki
North Carolina Medical Journal|September 1, 2019
More Than Health Care Services: North Carolina's Focus on Improving Whole-person Health and Patient ExperienceKaren E Michael
Nursing Management|June 7, 2002
DNR orders: proceed with cautionJanet E Michael
Journal of Muscle Research and Cell Motility|March 13, 2003
2,3-Butanedione monoxime (BDM) as a myosin inhibitorE Michael Ostap
Home Healthcare Nurse|August 15, 2003
What home healthcare nurses should know about fraud and abuseJanet E Michael
Expert Opinion on Investigational Drugs|October 10, 2007
Bazedoxifene and bazedoxifene combined with conjugated estrogens for the management of postmenopausal osteoporosisE Michael Lewiecki
Expert Opinion on Biological Therapy|January 26, 2010
Denosumab--an emerging treatment for postmenopausal osteoporosisE Michael Lewiecki
Advances in Experimental Medicine and Biology|February 13, 2009
Tropomyosins as discriminators of myosin functionE Michael Ostap
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|September 2, 2008
A clinician's perspective on the use of zoledronic acid in the treatment of postmenopausal osteoporosisE Michael Lewiecki
Current Osteoporosis Reports|June 18, 2010
Bone densitometry and vertebral fracture assessmentE Michael Lewiecki
Pageof 278